drugset / Trial / NCT06809803
Extended-release Sodium Oxybate in Children
RandomizedCrossoverOpen-labelOther
Summary
The main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non-extended-release oxybates (Sodium oxybate or a medication with the combination of Calcium, magnesium, potassium, and sodium oxybates). The study will also assess the safety, convenience, and tolerability of Extended-release sodium oxybate. Additionally, the researchers aim to assess how well Extended-release sodium oxybate works in treating narcolepsy type 1.
Timeline
- Start
- 2025-10-27
- Primary completion
- 2027-06
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Oxybate | Unknown | 4.5 g | Oral |
| Subject | Sodium Oxybate | Unknown | 9 g | Oral |